CONQUESTAmlitelimabSScsystemic sclerosis
…(anti-OX40L monoclonal antibody) is currently being explored in CONQUEST, a multicentre randomised controlled platform trial for SSc-ILD…
1articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: CONQUEST ×
CONQUEST
This institution is selected. Its supporting articles are shown below.